Lawsuit says Novo, OptumRx 'mutually benefited' from rebate scheme, while consumers paid the price

26th May 2017 Uncategorised 0

Novo Nordisk is the target, along with pharmacy benefit manager OptumRX, of a new proposed class action lawsuit claiming a conspiracy to raise the price of diabetes medicines so that the drugmaker could pay rebates to the pharmacy benefit manager.

More: Lawsuit says Novo, OptumRx 'mutually benefited' from rebate scheme, while consumers paid the price
Source: fierce